• infocencad


What is gender- based violence (GBV)?

Gender- based violence is a violence directed to a person based on his/ her biological sex or identity. It is global threat or pandemic affecting different categories of individuals. Gender- based violence (GBV) is usually regarded as violence against women and girls (VAWG); this is due to the fact that most women and girls suffer it the most. Data had evidently shown that 1 in 3 women are affected as a result of GBV in their lifetime (World Bank, 2019).

Forms of GBV?

Gender- based violence can occur anywhere in the private or public sphere, in the kitchen, bedrooms, streets, markets, schools or offices. It is therefore important to identify different forms of GBV. GBV could be physical, psychological or sexual, these could arise from threat, coercion, deprivation of liberty, humiliation, intimidation blames, hurts, or injury.

Why GBV must be discussed?

Addressing gender- based violence is necessary; in fact action against GBV is now not anytime. Research has evidently shown that countries with high prevalence of violence against women and girls also experience high prevalence of HIV (Patel et al., 2020). 38% of women encounter violence either from an intimate partner or non- partner globally (Allsworth & Goldman, 2017).

Africa had the highest occurrences of violence against women with about 46%, 37% occurs from an intimate partner while 12% from non- partner, this is followed by the Eastern Mediterranean with 40% (Allsworth & Goldman, 2017).


Allsworth, J. E., & Goldman, M. B. (2017). Populations at Special Health Risk: Women. International Encyclopedia of Public Health, 609–616. https://doi.org/10.1016/B978-0-12-803678-5.00350-7

Gender-Based Violence (Violence Against Women and Girls). (n.d.). Retrieved November 30, 2021, from https://www.worldbank.org/en/topic/socialsustainability/brief/violence-against-women-and-girls

Patel, P., Raizes, E., & Broyles, L. N. (2020). Human Immunodeficiency Virus Infection. Hunter’s Tropical Medicine and Emerging Infectious Diseases, 232–266. https://doi.org/10.1016/B978-0-323-55512-8.00031-4

39 views1 comment